These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7173317)

  • 21. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A possible mechanism of the tyramine-induced head-twitch response.
    Orikasa S; Kisara K
    Eur J Pharmacol; 1982 May; 80(2-3):163-9. PubMed ID: 6213417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural changes induced by N,N-dimethyl-tryptamine in rodents.
    Jenner P; Marsden CD; Thanki CM
    Br J Pharmacol; 1980 May; 69(1):69-80. PubMed ID: 6769527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that serotonin mediates some behavioral effects of amphetamine.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ; Marsden CA; Martin KF; Palfreyman MG
    Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of amphetamine derivatives on brain dopamine and noradrenaline.
    Breese GR; Kopin IJ; Weise VK
    Br J Pharmacol; 1970 May; 38(3):537-45. PubMed ID: 4909707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat.
    Juorio AV
    Br J Pharmacol; 1980 Nov; 70(3):475-80. PubMed ID: 6777007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the depletion of brain amines by m-tyrosine.
    Smyth RG; Tong JH; D'Iorio A
    Eur J Pharmacol; 1977 Apr; 42(3):267-73. PubMed ID: 323024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of some precursor amino acids and enzyme inhibitors on the mouse striatal concentration of tyramines and homovanillic acid.
    Juorio AV; Boulton AA
    J Neurochem; 1982 Sep; 39(3):859-63. PubMed ID: 7097290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats.
    Kennett GA; Dickinson SL; Curzon G
    Brain Res; 1985 Mar; 330(2):253-63. PubMed ID: 4039215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.
    Boban Blagaic A; Blagaic V; Mirt M; Jelovac N; Dodig G; Rucman R; Petek M; Turkovic B; Anic T; Dubovecak M; Staresinic M; Seiwerth S; Sikiric P
    Eur J Pharmacol; 2005 Apr; 512(2-3):173-9. PubMed ID: 15840402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slices.
    Dyck LE; Yang CR; Boulton AA
    J Neurosci Res; 1983; 10(2):211-20. PubMed ID: 6632007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ergot drugs on serotonergic function: behavior and neurochemistry.
    Silbergeld EK; Hruska RE
    Eur J Pharmacol; 1979 Sep; 58(1):1-10. PubMed ID: 315322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulatory role of catecholamines on tyrosine hydroxylase induction.
    Masana MI; Rubio MC
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 308(1):25-9. PubMed ID: 40139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of acute cocaine treatment on the turnover of 5-hydroxytryptamine in the rat brain.
    Friedman E; Gershon S; Rotrosen J
    Br J Pharmacol; 1975 May; 54(1):61-4. PubMed ID: 1139076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Backward walking and circling: a behavioural response to concurrent catecholamine and 5-hydroxytryptamine release [proceedings].
    Curzon G; Fernando JC; Lees AJ
    Br J Pharmacol; 1979 May; 66(1):119P-120P. PubMed ID: 454915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.